Monday, January 31, 2022 10:23:47 AM
Is it high risk...absolutely...if the regulators even get a whiff of Martin being involved in this in any way, it could be a disaster....but...with high risk comes the potential for high reward.
Leronlimab seems to draw a LOT of investor interest, take that interest and combine it with the microscopic float of RGMP.... and just simply due to the law of supply and demand.... the pps could fly.
I don't know what's going on with Martins stake in Phoenixus, sooner he's bought out the better as far as I'm concerned....but as long as he stays out of RGMP business, I like the odds.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM